Print

Print


EUROPE: MEPs Vote To Support Stem Cell Research

Decision puts pressure on governments to fund biomedical studies to cure wide range of diseases

Ian Black in Brussels
Thursday November 20, 2003
The Guardian

The European parliament yesterday voted to allow EU money to be spent on controversial stem cell research in the face
of bitter condemnation from some campaign groups.

The move puts pressure on member governments to free between €40m and €50m for strictly controlled studies that use
human embryos to find treatments for conditions such as Parkinson's disease and Alzheimer's.

MEPs yesterday voted by 291 to 235 to support new quality and safety standards for "the manipulation of tissues and
cells" after intense lobbying by patients' groups and medical researchers.

This highly divisive issue split the parliament down the middle earlier this year. However, the landmark decision is
not binding. The last word still rests with member states.

They will ultimately decide whether to lift a moratorium that prevents cash from Brussels being spent on such
experiments.

Catholic countries such as Germany, Italy, Portugal and Austria are unlikely to approve of the spending, though the
European commission has argued that Europe risks falling behind in a profitable area of biotechnology unless funds are
provided.

The new rules would allow researchers to spend EU money to harvest new stem cells from frozen human embryos under
certain conditions.

Yesterday's vote in Strasbourg was hailed as a significant advance by those in favour of stem cell research.

"We have been working closely with patients' groups and British biomedical researchers who lead the world in this
research," said Eryl McNally, a Labour MEP. "This is not research done out of idle curiosity. It is done with the aim
of bringing hope to sufferers from some very serious diseases."

The UK Association of Medical Research Charities welcomed the vote.

"We see no reason why there should be a restriction on using EU funds," a spokesman, Simon Festing, said.

"The EU cannot in any case fund something that is illegal in a member state."

Nick Clegg, a Liberal Democratic MEP, said: "There are many ethical concerns surrounding the issue of stem cell
research, but it is important such research can go ahead under an agreed framework of safety and quality rules."

Opponents of the decision insisted the go-ahead will mean destroying a potentially viable human embryo.

"It is a terrible thing that this has been agreed," the Irish MEP, Dana Scallon, protested yesterday.

"This will fund research using human life as though it were an instrument in a laboratory."

Stem cells, which scientists believe could be used to treat a wide range of degenerative diseases, can potentially grow
into any type of human tissue. Once harvested, they can be kept growing in laboratories indefinitely.

Sweden, Finland, Greece, the Netherlands and Britain allow harvesting stem cells from so-called supernumerary embryos -
ones that are the result of in vitro fertilisation - under certain conditions.

Britain is the only EU member state that allows the creation of human embryos for stem cell procurement.

"No country is forced to do anything they believe is wrong but ethical issues are matters for national parliaments to
decide," said David Bowe, a Labour MEP.

"The opponents of stem cell research were trying to impose their view on the whole of Europe. The European parliament
agreed it was wrong to try to impose one ethical view. Europe can't be run as if it were a single state with a
religious consensus.

"There is no ethical consensus in Europe."

Opponents are also campaigning to amend the EU's tissues and cells directive and a planned UN resolution banning human
cloning.

Researchers say that Britain's liberal rules on human embryo stem cell research are starting to create a "reverse brain
drain effect" which is attracting scientists from the US, where the anti-abortion lobby, especially the Catholic
church, exerts a powerful influence.

President George Bush has prohibited federal funds from being used for research on human embryonic stem cell lines
created after August 2001. Critics say the ban impedes US research into potentially life-saving treatments.

SOURCE: The Guardian, UK
http://www.guardian.co.uk/eu/story/0,7369,1089056,00.html

Special reports:

European integration
http://www.guardianunlimited.co.uk/flash/0,5860,408196,00.html

France
http://www.guardian.co.uk/france/0,11882,681877,00.html

Germany
http://www.guardian.co.uk/germany/0,2759,184716,00.html

Italy
http://www.guardian.co.uk/italy/0,12576,823937,00.html

Austria
http://www.guardian.co.uk/austria/0,2759,184722,00.html

Cyprus
http://www.guardian.co.uk/cyprus/0,11551,639479,00.html

The euro
http://www.guardian.co.uk/euro/0,11306,606524,00.html

Turkey
http://www.guardian.co.uk/turkey/0,12700,852986,00.html

Useful links:

Europa (EU homepage)
http://europa.eu.int/index-en.htm

European parliament
http://www.europarl.eu.int/home/default_en.htm

Council of the European Union
http://ue.eu.int/en/summ.htm

European commission
http://europa.eu.int/comm/index_en.htm

European court of justice
http://curia.eu.int/en/index.htm

EU committee of the regions
http://www.cor.eu.int/

European Economic and Social Committee
http://www.esc.eu.int/

* * *

----------------------------------------------------------------------
To sign-off Parkinsn send a message to: mailto:[log in to unmask]
In the body of the message put: signoff parkinsn